X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (51) 51
index medicus (35) 35
renal tubular transport, inborn errors - chemically induced (33) 33
female (27) 27
hypercalciuria - chemically induced (22) 22
male (22) 22
nephrocalcinosis - chemically induced (22) 22
animals (14) 14
hypomagnesemia (13) 13
magnesium (13) 13
proton pump inhibitors - adverse effects (13) 13
risk factors (12) 12
aged (11) 11
middle aged (11) 11
renal tubular transport, inborn errors - metabolism (10) 10
adult (9) 9
antineoplastic agents - adverse effects (9) 9
research (9) 9
magnesium - metabolism (8) 8
cisplatin - adverse effects (7) 7
medicine, general & internal (7) 7
pharmacology & pharmacy (7) 7
cetuximab (6) 6
mice (6) 6
oncology (6) 6
renal tubular transport, inborn errors - diagnosis (6) 6
chemotherapy (5) 5
cisplatin (5) 5
colorectal neoplasms - drug therapy (5) 5
drug therapy (5) 5
kidney diseases (5) 5
proton pump inhibitors (5) 5
renal tubular transport, inborn errors - epidemiology (5) 5
renal tubular transport, inborn errors - genetics (5) 5
treatment outcome (5) 5
adolescent (4) 4
aged, 80 and over (4) 4
child, preschool (4) 4
complications and side effects (4) 4
diagnosis, differential (4) 4
diet (4) 4
diuretics (4) 4
endocrinology & metabolism (4) 4
expression (4) 4
hypercalciuria - epidemiology (4) 4
hypocalcemia - chemically induced (4) 4
kidney - drug effects (4) 4
kidney - metabolism (4) 4
magnesium - blood (4) 4
magnesium deficiency - congenital (4) 4
nephrocalcinosis - epidemiology (4) 4
prevalence (4) 4
renal tubular transport, inborn errors - blood (4) 4
therapy (4) 4
trpm6 (4) 4
analysis (3) 3
antibodies, monoclonal - adverse effects (3) 3
antibodies, monoclonal, humanized (3) 3
antineoplastic agents - administration & dosage (3) 3
antineoplastic agents - therapeutic use (3) 3
biomarkers - blood (3) 3
care and treatment (3) 3
cervical cancer (3) 3
child (3) 3
colorectal-cancer (3) 3
epidermal growth factor (3) 3
epilepsy (3) 3
excretion (3) 3
familial hypomagnesemia (3) 3
homeostasis (3) 3
hydration (3) 3
hypercalciuria - blood (3) 3
hypercalciuria - complications (3) 3
hypercalciuria - diagnosis (3) 3
hypercalciuria - etiology (3) 3
hypercalciuria - metabolism (3) 3
hypercalciuria - prevention & control (3) 3
hypokalemia - chemically induced (3) 3
internal medicine (3) 3
lipids (3) 3
magnesium deficiency diseases (3) 3
medicine & public health (3) 3
medicine, research & experimental (3) 3
metabolism (3) 3
mutation (3) 3
mutations (3) 3
nephrocalcinosis - blood (3) 3
nephrocalcinosis - complications (3) 3
nephrocalcinosis - diagnosis (3) 3
nephrocalcinosis - etiology (3) 3
nephrocalcinosis - metabolism (3) 3
nephrocalcinosis - prevention & control (3) 3
nephrotoxicity (3) 3
omeprazole - adverse effects (3) 3
oxidative stress (3) 3
pediatrics (3) 3
proteins (3) 3
rats (3) 3
renal tubular transport, inborn errors - complications (3) 3
renal tubular transport, inborn errors - etiology (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 2005, Volume 115, Issue 6, pp. 1651 - 1658
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 2007, Volume 117, Issue 8, pp. 2260 - 2267
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2013, Volume 126, Issue 3, pp. 256 - 263
Journal Article
Journal Article
Journal of Clinical Gastroenterology, ISSN 0192-0790, 02/2012, Volume 46, Issue 2, pp. 93 - 114
Journal Article
Journal Article
Current Opinion in Nephrology and Hypertension, ISSN 1062-4821, 05/2016, Volume 25, Issue 4, pp. 301 - 307
PURPOSE OF REVIEWIdentification of the mechanisms of magnesium absorption and reabsorption has markedly enhanced our understanding of the causes of... 
TRPM6/7 | hypomagnesemia | hereditary causes of hypomagnesemia | proton pump inhibitors | epidermal growth factor | FAMILIAL HYPOMAGNESEMIA | DISORDERS | MAGNESIUM | HYPERCALCIURIA | TRANSPORT | CLDN19 | UROLOGY & NEPHROLOGY | PERIPHERAL VASCULAR DISEASE | MUTATIONS | KIDNEY | TRPM6 | EXPRESSION | Hypocalcemia - metabolism | Humans | Sodium Potassium Chloride Symporter Inhibitors - adverse effects | Water-Electrolyte Imbalance - etiology | Intestines - metabolism | Pancreatitis - complications | Nephrocalcinosis - complications | Magnesium Deficiency - complications | Nephrocalcinosis - metabolism | Renal Tubular Transport, Inborn Errors - metabolism | Bartter Syndrome - metabolism | Hypocalcemia - complications | Intestinal Elimination | Proton Pump Inhibitors - adverse effects | Hypoparathyroidism - congenital | Magnesium Deficiency - congenital | Water-Electrolyte Imbalance - chemically induced | Bartter Syndrome - complications | Magnesium - metabolism | Renal Tubular Transport, Inborn Errors - complications | Magnesium Deficiency - metabolism | Hypoparathyroidism - metabolism | Renal Elimination | Hypercalciuria - complications | Water-Electrolyte Imbalance - metabolism | Hypercalciuria - metabolism | Gitelman Syndrome - complications | Hypoparathyroidism - complications | Gitelman Syndrome - metabolism | Pancreatitis - metabolism | Nephrons - metabolism
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 08/2007, Volume 117, Issue 8, pp. 2086 - 2089
Journal Article
Annals of Oncology, ISSN 0923-7534, 04/2013, Volume 24, Issue 4, pp. 953 - 960
Journal Article
Experimental Cell Research, ISSN 0014-4827, 03/2019, Volume 376, Issue 2, pp. 210 - 220
Cetuximab, an inhibitor of the epidermal growth factor receptor that is used widely to treat human cancers including oral squamous cell carcinoma (OSCC), has... 
p38 | SB203580 | Flavagline | TRPM6 | Tumor growth suppression | Cetuximab side effects | CARCINOMA-CELLS | APOPTOSIS | ACTIVATION | PLUS CETUXIMAB | KINASE | PROLIFERATION | CELL BIOLOGY | P38 | CISPLATIN | ONCOLOGY | COLORECTAL-CANCER | Cetuximab side effects p38 | EXPRESSION | Mouth Neoplasms - complications | Mouth Neoplasms - drug therapy | Exanthema - genetics | Humans | Transcriptome | Renal Tubular Transport, Inborn Errors - chemically induced | Renal Tubular Transport, Inborn Errors - genetics | Gene Regulatory Networks | Cetuximab - adverse effects | Exanthema - chemically induced | Hypercalciuria - chemically induced | Hypercalciuria - prevention & control | HEK293 Cells | Nephrocalcinosis - prevention & control | Exanthema - prevention & control | Female | Hypercalciuria - genetics | Gene Expression Regulation, Neoplastic - drug effects | Imidazoles - therapeutic use | Drug Therapy, Combination | Mouth Neoplasms - genetics | Pyridines - therapeutic use | ErbB Receptors - antagonists & inhibitors | Nephrocalcinosis - chemically induced | Xenograft Model Antitumor Assays | Growth Inhibitors - therapeutic use | Antineoplastic Agents, Immunological - adverse effects | Animals | Carcinoma, Squamous Cell - drug therapy | MAP Kinase Signaling System - drug effects | Nephrocalcinosis - genetics | Mice, Nude | Carcinoma, Squamous Cell - complications | Cell Line, Tumor | Mice | Mice, Inbred BALB C | Renal Tubular Transport, Inborn Errors - prevention & control | Growth Inhibitors - adverse effects | Growth Inhibitors - antagonists & inhibitors | Medical colleges | Squamous cell carcinoma | Growth | Dermatology | Dermatologic agents | Gene expression | Complications and side effects | Epidermal growth factor | Analysis | Formulae, receipts, prescriptions | Skin diseases | Skin | Drug therapy
Journal Article